Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Endocrinology | Psychiatry/Psychology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Forest Laboratories
Approval Status: Approved July 1998
Treatment Area: Depression
A highly selective SSRI, Celexa is the best-selling
antidepressant in 13 countries, including eight in Europe.
Celexa has been proven effective and well tolerated in clinical
trials involving more than 23,000 Celexa-treated patients, as well
as by a decade of clinical use during which more than eight million
people in 64 countries have been treated with Celexa. Results from
these trials show that Celexa consistently and significantly
improves symptoms of depression, regardless of patient age, race or
gender. In addition, studies have also shown that Celexa is
significantly more effective than placebo in preventing relapse of
depression.
Side effects reported include nausea, dry mouth and
sleepiness.
Precautions:
As with others SSRIs, Celexa should not be taken together with
monoamine oxidase inhibitors.
